An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum
By the legal team of ProCAncer-I, The University of Vienna Department of Innovation and Digitalisation in Law (UNIVIE) Given the innovative nature of the technology being developed in the ProCAncer-I project, complex legal questions have arisen concerning the...
Editorial by Prof Manolis Tsiknakis, Coordinator of ProCAncer-I project The ProCAncer-I consortium welcomes you to our first newsletter! We are very happy that our project ProCAncer-I on dealing with prostate cancer was funded by the EU and that through its successful...
Βy Prof. Daniele Regge [Chief of the Radiology Unit, Candiolo Cancer Institute, Torino-Italy] and Simone Mazzetti [Candiolo Cancer Institute, Torino-Italy] Prostate cancer is the most frequently diagnosed tumour in Europe with one new cancer detected every...
Βy Prof Kostas Marias [Foundation for Research and Technology - Hellas (FORTH)], Ioannis Karatzanis [Foundation for Research and Technology - Hellas (FORTH)] and Katerina Nikiforaki [Foundation for Research and Technology - Hellas (FORTH)] Anonymization is an...
Βy Nickolas Papanikolaou [Principal Investigator in Oncologic Imaging at the Fundação Champalimaud] Why did you select prostate cancer as the center of your research? What kind of clinical unmet needs will be addressed in ProCancer-I? Prostate cancer is among the most...
By the Radboud UMC Radboudumc is one of the leading centres for prostate cancer imaging worldwide. Within the ProCAncer-I project, two groups of the Department of Imaging of Radboudumc are represented. The Diagnostic Image Analysis Group (DIAG), under the...
By the University of Vienna – Department of Innovation and Digitalisation in Law (UNIVIE) The University of Vienna is the oldest University in the German-speaking world, and the Department of Innovation and Digitalisation in Law is the newest addition to the...
Newsletter #1 Contents
How could AI improve prostate cancer diagnosis? This video from the research group of prof. Daniele Regge (coordinator of the clinical activities) explains AI application to prostate MRI.
by Emily Johnson and Theresa Henne Age Weight PSA value Gleason Group 33 112,2 kg 7,9 ng/ml 3+4 Table 1. Is this data anonymous? Data sample of a fictional prostate cancer patient Imagine you stumble across the information given above - it may be part of...
Our researchers received the Best Student Paper Award in Bioengineering category in the 21st IEEE International Conference on BioInformatics and BioEngineering that was held on October 25-27, 2021, at Kragujevac (Serbia). The award-winning paper is entitled: "A Deep...
On Monday the 25th of October 2021, our researchers participated in the virtual meeting on "Artificial Intelligence: a new age of radiology?" organized by University of Torino with prof. Daniele Regge as Chairman. Aim of the Residents’ radiology online meeting- II...
[custom-twitter-feeds]